EMEA-001915-PIP01-15-M03 - paediatric investigation plan
Volanesorsen
PIPHuman
Akcea Therapeutics
Tel. +1 6172070202
E-mail: info@akceatx.com
P/0131/2021: EMA decision of 14 April 2021 on the acceptance of a modification of an agreed paediatric investigation plan for volanesorsen (Waylivra), (EMEA-001915-PIP01-15-M03)